Earnings6 reported quarters · next on Feb 11, 2027
Earnings
Quarter
EPS
EPS expected
Revenue
Revenue expected
Result
Q3 FY2026reported Nov 2, 2026
-$1.15
-$1.04
$12.7M
$14.8M
EPS miss, GAAPRevenue miss
Q2 FY2026reported Aug 3, 2026
-$0.94
-$1.19
$10.2M
$7.4M
EPS beat, GAAPRevenue beat
Q1 FY2026reported May 4, 2026
-$1.28
-$1.19
$1.5M
$6.1M
EPS miss, GAAPRevenue miss
Q4 FY2025reported Feb 12, 2026
-$1.37
-$1.15
$864K
$4.7M
EPS missRevenue miss
Q3 FY2025reported Nov 10, 2025
-$1.17
-$1.26
$889K
$9.1M
EPS beat, GAAPRevenue miss
Q2 FY2025reported Aug 5, 2025
-$2.40
-$1.47
$892K
$6.1M
EPS miss, GAAPRevenue miss
Actual against the consensus estimate at the time. A flag marks a beat or a miss of more than 1.5% either way; inside that band the quarter is in line. A flag marked GAAP compares a GAAP figure the company reported with an adjusted consensus, two different measures, so a one-time gain or charge can move it either way. A flag reads n/a only when a number is missing. Quarterly EPS is the figure set against the consensus, usually adjusted, so the quarters need not add up to the 12-month net income per share above. An estimate is a forecast made by analysts, not a company target.
Each firm's latest price target on CRSP, newest first
Firm
Rating
Target
Action
Date
Piper Sandler
Overweight
$110
Target set
Wells Fargo
Equal Weight
$70
Cut from $75
UBS
Neutral
$52
Initiated
Goldman Sachs
Neutral
$55
Target set
H.C. Wainwright
Buy
$80
Target set
Morgan Stanley
Equalweight
$60
Target set
Bernstein
Market Perform
$56
Target set
Evercore ISI
Not stated
$76
Raised from $74
Chardan
Buy
$76
Raised from $74
Needham
Buy
$82
Target set
Each firm's latest target from the past year, with the rating stated with its note or within three days of it. These are the firms' own views, not GetSignal's, and we do not endorse them. Not investment advice.
3 other firms rated CRSP in the past year with no current target listed here. Ratings and targets come from licensed market data providers. A target is listed only after its firm and company are confirmed against a report of the note. As of Nov 12, 2026.
A 13F reports long US equity positions and is filed within 45 days of the quarter end, so these are positions as they stood on Jun 30, 2026. For a manager's whole book see the fund directory. What a 13F covers and leaves out is explained in our guide to Form 13F.
One row is one filing, newest filing first. A filing that reported its trade in several tranches is summed, priced at the weighted average, and marked with its line count. Scheduled: set up in advance under a Rule 10b5-1 trading plan. The delay counts business days from the trade to the filing, the unit of Form 4's two business day deadline: weekends and federal holidays are skipped. How the filing itself works is explained in our guide to Form 4.
Awards, option exercises, shares withheld to cover tax and gifts all file on the same form as a purchase or a sale. None of them is a decision to trade, so they sit here rather than beside the ones that are.
STOCK Act3 disclosures · median 29d of the 45 allowed
Congress trades in CRSP
Since the trade: the stock's move from its estimated entry price (a purchase) or estimated exit price (a sale) to its current price, the latest close we hold. Not the member's result.
-75.3%since the tradeEstimated entry price $185.10, close on Thu Jan 21, 2021Current price $45.75, close on Wed Nov 11
Jan 21, 2021
Feb 19, 2021
29d
Estimated prices are the stock's closing price on the trade date. A disclosure gives a value band, not the price paid. Not investment advice. After a sale a positive figure means the stock kept rising after it. On an option line the prices are the stock's, never the option's: the premium is never disclosed.
A delay above 45 days is the gap between the dates on the report; we mark a filing late only after checking it.
"Not captured" means the band or the transaction type on the original report is missing from our data.
"Dates conflict" marks a row whose disclosure is dated before its trade on the record we hold. Both dates are printed as filed, and no prices or move are shown for that row.
A congressional disclosure names a company by its ticker symbol alone, and a symbol can be reassigned after its previous holder leaves the market. One disclosure filed under CRSP is dated before this company began trading under it, and is not shown here.
Congress rows disclose a value range rather than an exact amount, and the STOCK Act allows up to 45 days to report. Full sourcing and the limits of this data are on the methodology page. A filing is a record of a transaction, not a signal, and nothing here is investment advice.
On Form 4, code P is an open-market purchase and S an open-market sale; a sale marked scheduled was set up in advance under a Rule 10b5-1 plan. Awards, option exercises, tax withholding and gifts (A, M, F and G) are listed under Other Form 4 activity and never counted as either.
A STOCK Act disclosure gives each trade as a band of dollar values, which we do not narrow, and is due within 45 days of the trade. An option is described by its underlying company's name; its row says it is an option.
What the filings on CRSP show and how current they are.
Are insiders buying or selling CRSP?
Across the 10 most recent open-market filings shown here, 0 were purchases and 10 were sales. 3 were scheduled in advance under a Rule 10b5-1 plan.
Which members of Congress have traded CRSP?
Thomas R. Suozzi and Marjorie Taylor Greene disclosed CRSP transactions in the filings shown here.
How quickly are CRSP trades disclosed?
Insider filings on this page reached the public a median of 1 business day after the transaction (weekends and federal holidays skipped), against the two business days Form 4 allows. Congressional disclosures took a median of 29 days, against the 45 the STOCK Act allows.